Bio Green Med Solution (BGMS) Cash from Operations Growth (5y) (2015 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.60 Bn | 132.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.04 Bn | 79.04 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 58.38 Bn | 53.25 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.21 Bn | 31.90 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.01 Bn | 27.17 Bn | - |
| 9 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.14% |
| Mar 31, 2026 | 39.97% |
| Dec 31, 2025 | 50.86% |
| Sep 30, 2025 | 27.25% |
| Jun 30, 2025 | 10.57% |
| Mar 31, 2025 | -2.96% |
| Dec 31, 2024 | -3.95% |
| Sep 30, 2024 | -8.81% |
| Jun 30, 2024 | -3.20% |
| Mar 31, 2024 | 33.39% |
| Dec 31, 2023 | -13.94% |
| Sep 30, 2023 | -41.05% |
| Jun 30, 2023 | 6.26% |
| Mar 31, 2023 | -26.25% |
| Dec 31, 2022 | -18.42% |
| Sep 30, 2022 | -41.03% |
| Jun 30, 2022 | -56.96% |
| Mar 31, 2022 | -12.20% |
| Dec 31, 2021 | -9.10% |
| Sep 30, 2021 | -16.03% |